Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
China flag China · Delayed Price · Currency is CNY
12.76
-0.39 (-2.97%)
Nov 17, 2026, 4:00 PM EST

SHE:301408 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,388957.971,0021,336482.1284.51
Trading Asset Securities
134221012.41-0.5
Cash & Short-Term Investments
1,522979.971,0121,349482.1285.01
Cash Growth
76.58%-3.13%-24.99%179.76%69.16%23.37%
Accounts Receivable
587.66588.83472.6513.14470.77294.32
Other Receivables
59.179.68.8136.2434.5230.82
Receivables
646.82598.43481.42549.38505.29325.14
Inventory
1,0991,055863.84772.09545.01436.19
Prepaid Expenses
-13.5515.638.272.524.22
Other Current Assets
226.15266.34224.87147.78165.2262.74
Total Current Assets
3,4942,9132,5972,8261,7001,113
Property, Plant & Equipment
992.51985967.8870.15533.42542.53
Long-Term Investments
70.5245.5282.292.8125.458.92
Goodwill
1,2991,282988.37609.31190.06190.06
Other Intangible Assets
87.6163.967.2162.51338.26
Long-Term Deferred Tax Assets
51.951.7840.6532.8321.9215.17
Long-Term Deferred Charges
102.1182.9659.0352.1158.9792.32
Other Long-Term Assets
54.263.8425.4865.7413.230.5
Total Assets
6,1525,4884,8284,6122,5761,971

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
1,9121,6661,1581,027698.74468.23
Accrued Expenses
61.68174.24140.2599.84101.6879.98
Short-Term Debt
718.03345.3316.92513.51340.31150.77
Current Portion of Long-Term Debt
367.02179.36116.0210.25--
Current Portion of Leases
-199.71210.44193.64154.24144
Current Income Taxes Payable
54.6238.1420.6312.334.6313.15
Current Unearned Revenue
39.3242.8637.1127.0619.4111.25
Other Current Liabilities
124.4139.74178.9480.3112.715.25
Total Current Liabilities
3,2772,6862,1791,9641,362882.64
Long-Term Debt
405.62407.08358.83331.1518.95-
Long-Term Leases
196.87220.08222.85237.65248.51303.03
Long-Term Unearned Revenue
1.921.810.810.91--
Long-Term Deferred Tax Liabilities
5.876.26.656.32--
Other Long-Term Liabilities
4.54.5-95.4-0.33
Total Liabilities
3,8923,3252,7682,6351,6291,186

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
400.01400.01400.01400.01340340
Additional Paid-In Capital
842.8916.8977.861,014194.7192.99
Retained Earnings
955.71780.17627.42529.39412.58251.81
Total Common Equity
2,1992,0972,0051,944947.28784.8
Minority Interest
61.4566.1355.1433-0.270.25
Shareholders' Equity
2,2602,1632,0601,977947.01785.05
Total Liabilities & Equity
6,1525,4884,8284,6122,5761,971

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
1,6881,3521,2251,286762.02597.8
Net Cash (Debt)
-165.59-371.57-213.4362.53-279.92-312.8
Net Cash Growth
------
Net Cash Per Share
-0.42-0.93-0.530.16-0.82-0.94
Filing Date Shares Outstanding
400.01400.01400.01400.01340340
Total Common Shares Outstanding
400.01400.01400.01400.01340340
Working Capital
216.79227.37418.84862.52338.42230.65
Book Value Per Share
5.505.245.014.862.792.31
Tangible Book Value
811.8750.67949.711,272724.22586.49
Tangible Book Value Per Share
2.031.882.373.182.131.72
Buildings
-382.39219.2238.7323.1523.15
Machinery
-337.07297.24270.1679.3865.74
Construction In Progress
-34.73168.6661.3432.240.25